Paris - Delayed Quote EUR
TME Pharma N.V. (ALTME.PA)
0.0730
+0.0010
+(1.39%)
At close: 5:11:54 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-4,634
-4,634
-5,635
-12,143
-12,381
Investing Cash Flow
-21
-21
-19
-21
-14
Financing Cash Flow
5,660
5,660
3,266
7,285
11,498
End Cash Position
3,240
3,240
2,245
4,634
9,456
Capital Expenditure
-16
-16
-19
-21
-14
Issuance of Capital Stock
7,281
7,281
3,383
85
7,219
Issuance of Debt
0
0
1,004
7,431
4,371
Repayment of Debt
-1,155
-1,155
-943
0
--
Repurchase of Capital Stock
-2
-2
-1
-29
-1
Free Cash Flow
-4,650
-4,650
-5,654
-12,164
-12,395
12/31/2021 - 9/30/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IDIAz.XC
BIOV.SW BioVersys N
34.70
0.00%
VSC.F 4SC AG
2.4800
0.00%
HPHA.DE Heidelberg Pharma AG
3.2000
+2.56%
NYKD.OL Nykode Therapeutics AS
2.6620
-4.38%
VVY.AS Vivoryon Therapeutics N.V.
1.7280
-1.48%
ALNEV.PA Neovacs S.A.
0.0068
+3.03%
ALCLS.PA Cellectis S.A.
1.3480
+3.37%
GOVXW GeoVax Labs, Inc.
0.0439
+12.28%
VICO.ST Vicore Pharma Holding AB (publ)
8.55
+8.64%